Peptide drugs represent 5% of the global pharmaceutical market, but growing twice as fast as the rest of the drug market. The development of peptide therapeutics is challenging due to their low stability, short half-life, and poor oral bioavailability. However, peptides typically have exquisite potency, selectivity, and low toxicity, making them particularly attractive for certain disease targets. Significant technological innovations have enabled the rapid advancement of

Strategies to Optimize Peptide Stability and Prolong Half-Life

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Journal Info